CVS Health (NYSE:CVS) Updates FY 2022 Earnings Guidance

CVS Health (NYSE:CVS – Get Rating) issued an update on its FY 2022 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $8.20-$8.40 for the period, compared to the consensus estimate of $8.36. The company issued revenue guidance of -. Shares of NYSE:CVS opened at $91.45 on Thursday. The company […]

Related Keywords

United States ,Sanfordc Bernstein ,Prems Shah ,Danielp Finke , ,Deutsche Bank Aktiengesellschaft ,Cvs Health ,Ensign Peak Advisors Inc ,Clearbridge Investments ,Industrial Alliance Investment Management Inc ,Charles Schwab Investment Management Inc ,Health Corporation ,Capital Research Global Investors ,Health Get Rating ,Health Care ,Get Rating ,Bank Aktiengesellschaft ,Tigress Financial ,Schwab Investment Management ,Research Global Investors ,Peak Advisors Inc ,Industrial Alliance Investment Management ,Alliance Investment Management ,Health Care Benefits ,Nyse Cvs ,Cvs ,Retail Wholesale ,12665010 ,Guidance ,Earnings ,Preannouncement ,